Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.
Limdi NA, Cavallari LH, Lee CR, Hillegass WB, Holmes AM, Skaar TC, Pisu M, Dillon C, Beitelshees AL, Empey PE, Duarte JD, Diaby V, Gong Y, Johnson JA, Graves J, Garbett S, Zhou Z, Peterson JF; Implementing GeNomics In pracTicE (IGNITE) Network Pharmacogenetic Working Group (IGNITE-PGx). Limdi NA, et al. Among authors: cavallari lh. Pharmacogenomics J. 2020 Oct;20(5):724-735. doi: 10.1038/s41397-020-0162-5. Epub 2020 Feb 11. Pharmacogenomics J. 2020. PMID: 32042096 Free PMC article.
Cardiovascular pharmacogenomics.
Johnson JA, Cavallari LH. Johnson JA, et al. Among authors: cavallari lh. Exp Physiol. 2005 May;90(3):283-9. doi: 10.1113/expphysiol.2004.028506. Epub 2005 Mar 18. Exp Physiol. 2005. PMID: 15778411 Free article. Review.
Warfarin pharmacogenomics.
Cavallari LH, Limdi NA. Cavallari LH, et al. Curr Opin Mol Ther. 2009 Jun;11(3):243-51. Curr Opin Mol Ther. 2009. PMID: 19479657 Review.
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ; International Warfarin Pharmacogenetics Consortium. Limdi NA, et al. Blood. 2010 May 6;115(18):3827-34. doi: 10.1182/blood-2009-12-255992. Epub 2010 Mar 4. Blood. 2010. PMID: 20203262 Free PMC article.
Warfarin dosing in patients with impaired kidney function.
Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, Baird MF, Allon M, Beasley TM. Limdi NA, et al. Am J Kidney Dis. 2010 Nov;56(5):823-31. doi: 10.1053/j.ajkd.2010.05.023. Epub 2010 Aug 14. Am J Kidney Dis. 2010. PMID: 20709439 Free PMC article.
Pharmacogenomics: application to the management of cardiovascular disease.
Johnson JA, Cavallari LH, Beitelshees AL, Lewis JP, Shuldiner AR, Roden DM. Johnson JA, et al. Among authors: cavallari lh. Clin Pharmacol Ther. 2011 Oct;90(4):519-31. doi: 10.1038/clpt.2011.179. Epub 2011 Sep 14. Clin Pharmacol Ther. 2011. PMID: 21918509 Free PMC article.
204 results